DOI QR코드

DOI QR Code

제1형 신경섬유종증 환자에서 발생한 양측성 유방암: 증례 보고

Bilateral Breast Cancer in a Patient with Neurofibromatosis Type 1: A Case Report

  • 우상화 (인제대학교 의과대학 해운대백병원 영상의학과) ;
  • 정현경 (인제대학교 의과대학 해운대백병원 영상의학과) ;
  • 김우경 (인제대학교 의과대학 해운대백병원 병리과)
  • Sang Hwa Woo (Department of Radiology, Inje University Haeundae Paik Hospital) ;
  • Hyun Kyung Jung (Department of Radiology, Inje University Haeundae Paik Hospital) ;
  • Woogyeong Kim (Department of Pathology, Inje University Haeundae Paik Hospital)
  • 투고 : 2020.05.06
  • 심사 : 2020.06.20
  • 발행 : 2021.03.01

초록

제1형 신경섬유종증은 상염색제 우성으로 유전되는 신경외배영성 질환으로 다양한 악성 종양이 발생할 수 있다. 하지만 유방암이 발생한 보고는 드물다. 이에 저자들은 제1형 신경섬유종증 환자에서 발생한 양측성 유방암 증례를 영상 소견과 함께 보고하고자 한다.

Neurofibromatosis type 1 (NF1) is a rare neuroectodermal disease that is associated with an increased risk of malignancy. Here, we report a rare case of bilateral breast cancer in a 49-year-old woman with NF1 that presented as a microlobulated oval hypoechoic mass and a complex cystic solid mass on sonography. She underwent bilateral mastectomy. The masses were diagnosed as invasive ductal carcinoma, ductal carcinoma in situ, and a malignant peripheral nerve sheath tumor. We describe the imaging findings, including ultrasonography, CT, and 18F-fluorodeoxyglucose PET.

키워드

참고문헌

  1. Dursun D, Akta,s S, Altun Z, Olgun N. Bilateral breast cancer with neurofibromatosis type 1 patient: case report. Eur J Breast Health 2017;13:213-215
  2. Seo YN, Park YM. Association between neurofibromatosis type 1 and breast cancer: a report of two cases with a review of the literature. Case Rep Med 2015;2015:456205
  3. Kim SH, Son WJ, Sin DJ, Chang MC. Bilateral metachronous breast cancer in neurofibromatosis type 1. J Korean Surg Soc 2009;76:388-391
  4. Alamsamimi M, Mirkheshti N, Mohajery MR, Abdollahi M. Bilateral invasive ductal carcinoma in a woman with neurofibromatosis type 1. Arch Iran Med 2009;12:412-414
  5. Bonnet SE, Kang-Chapman JK, Buckley KA, Cui X, Grignol VP, Hawley JR. Malignant peripheral nerve sheath tumor of the breast in a patient with neurofibromatosis 1. Breast J 2018;24:1066-1068
  6. Maani N, Westergard S, Yang J, Scaranelo AM, Telesca S, Thain E, et al. NF1 patients receiving breast cancer screening: insights from the Ontario high risk breast screening program. Cancers (Basel) 2019;11:707
  7. Sharif S, Moran A, Huson SM, Iddenden R, Shenton A, Howard E, et al. Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening. J Med Genet 2007;44:481-484
  8. Madanikia SA, Bergner A, Ye X, Blakeley JO. Increased risk of breast cancer in women with NF1. Am J Med Genet A 2012;158A:3056-3060
  9. Shuayb M, Begum R. Unusual primary breast cancer - malignant peripheral nerve sheath tumor: a case report and review of the literature. J Med Case Rep 2017;11:161
  10. Yap YS, Munusamy P, Lim C, Chan CHT, Prawira A, Loke SY, et al. Breast cancer in women with neurofibromatosis type 1 (NF1): a comprehensive case series with molecular insights into its aggressive phenotype. Breast Cancer Res Treat 2018;171:719-735